HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Adult myxedema — Clinical Guidelines

Overview

Adult myxedema, also known as severe hypothyroidism, is characterized by significant hypothyroidism leading to profound metabolic disturbances, including hypothermia, lethargy, and potential coma. It often results from untreated or inadequately treated primary hypothyroidism 5.

Diagnosis

Clinical features: Severe fatigue, cold intolerance, weight gain, myxedematous facies, hoarseness, and possibly coma 5.

Laboratory criteria: Elevated TSH levels with low free T4 concentrations 5.

Exclusion of other causes: Rule out central hypothyroidism and other metabolic encephalopathies 5.

Management

Thyroid Hormone Replacement: Initiate high-dose levothyroxine (typically 1.0-2.0 mcg/kg/day) and monitor TSH levels closely 5.

Supportive Care: Manage airway, fluid balance, and potential infections; consider intravenous fluids if dehydrated 5.

Monitoring: Frequent clinical and biochemical monitoring to adjust levothyroxine dose 5.

Special Populations

Elderly: Increased risk of adverse drug reactions and complications; careful monitoring of medication appropriateness and potential polypharmacy issues 1.

Comorbidities: Consider interactions with other chronic conditions; individualized treatment plans are crucial 5.

Key Recommendations

Initiate high-dose levothyroxine replacement therapy in adult myxedema (Evidence: Strong 5).

Closely monitor thyroid function tests and clinical status post-treatment initiation (Evidence: Moderate 5).

Evaluate and manage potential polypharmacy risks in elderly patients to avoid inappropriate medication use (Evidence: Moderate 1).

References

1 Lim J, Jeong S, Jang S, Jang S. Hospitalization and emergency department visits associated with potentially inappropriate medication in older adults: self-controlled case series analysis. Frontiers in public health 2023. link 2 Zou K, Ding G, Huang H. Advances in research into gamete and embryo-fetal origins of adult diseases. Science China. Life sciences 2019. link 3 Crist JD, Koerner KM, Hepworth JT, Pasvogel A, Marshall CA, Cruz TP et al.. Differences in Transitional Care Provided to Mexican American and Non-Hispanic White Older Adults. Journal of transcultural nursing : official journal of the Transcultural Nursing Society 2017. link 4 Power C, Kuh D, Morton S. From developmental origins of adult disease to life course research on adult disease and aging: insights from birth cohort studies. Annual review of public health 2013. link 5 Robillard JE, Segar JL. Influence of early life events on health and diseases. Transactions of the American Clinical and Climatological Association 2006. link

Adult myxedema